IDO1 and neoplasm: As shown in Fig. 2a, the ratios of Kyn (nM)/Trp (μM) in both blood and tumours were significantly reduced following the treatment of PEG2k-Fmoc-NLG(L) while a more dramatic reduction was observed in the tumour tissues, consistent with the intended preferential delivery of IDO inhibitors to the tumour tissues.